Frontiers in cardiovascular medicine · 2026
Interpretable machine learning and mendelian randomization identify risk factors for lower extremity arterial embolism and thrombosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Xiaodong, Wei Guohao, Liu Rui, Jiang Qiulin, Ma Yarong, Sun Xiaolei
Аннотация
BACKGROUND: Lower extremity arterial embolism and thrombosis lead to significant morbidity, but their risk factors are not fully characterized.
OBJECTIVES: To identify risk factors and develop an interpretable machine learning (ML) model for predicting lower extremity arterial embolism and thrombosis, with validation using mendelian randomization (MR).
METHODS: In this retrospective case-control study, data were collected from patients with lower extremity arterial embolism and thrombosis treated at our department of vascular surgery between January 2018 and November 2025. Predictors were selected using LASSO regression, and 11 ML models were developed using the selected variables. The optimal model was interpreted and implemented as a web-based prediction tool. Clinical utility and model calibration were assessed using decision curve analysis and calibration curves. Key predictors were further assessed using MR and multivariable logistic regression.
RESULTS: XGBoost achieved the highest discrimination, with an AUC of 0.951 (95% CI 0.925-0.972) in the test set. MR analyses indicated that genetically predicted cerebrovascular disease (CD) (OR 1.773; 95% CI 1.043-3.015; P = 0.035) and gamma-glutamyl transferase (GGT) (OR 1.327; 95% CI 1.105-1.595; P = 0.003) were risk factors, whereas mean platelet volume (MPV) was protective (OR 0.879; 95% CI 0.778-0.993; P = 0.038). Multivariable logistic regression confirmed CD (OR 10.19; 95% CI 4.36-23.82; P < 0.001) and MPV (OR 0.63; 95% CI 0.52-0.76; P < 0.001) as independent predictors.
CONCLUSIONS: Interpretable ML combined with MR identified a history of CD and lower MPV as factors associated with risk of lower extremity arterial embolism and thrombosis.
OBJECTIVES: To identify risk factors and develop an interpretable machine learning (ML) model for predicting lower extremity arterial embolism and thrombosis, with validation using mendelian randomization (MR).
METHODS: In this retrospective case-control study, data were collected from patients with lower extremity arterial embolism and thrombosis treated at our department of vascular surgery between January 2018 and November 2025. Predictors were selected using LASSO regression, and 11 ML models were developed using the selected variables. The optimal model was interpreted and implemented as a web-based prediction tool. Clinical utility and model calibration were assessed using decision curve analysis and calibration curves. Key predictors were further assessed using MR and multivariable logistic regression.
RESULTS: XGBoost achieved the highest discrimination, with an AUC of 0.951 (95% CI 0.925-0.972) in the test set. MR analyses indicated that genetically predicted cerebrovascular disease (CD) (OR 1.773; 95% CI 1.043-3.015; P = 0.035) and gamma-glutamyl transferase (GGT) (OR 1.327; 95% CI 1.105-1.595; P = 0.003) were risk factors, whereas mean platelet volume (MPV) was protective (OR 0.879; 95% CI 0.778-0.993; P = 0.038). Multivariable logistic regression confirmed CD (OR 10.19; 95% CI 4.36-23.82; P < 0.001) and MPV (OR 0.63; 95% CI 0.52-0.76; P < 0.001) as independent predictors.
CONCLUSIONS: Interpretable ML combined with MR identified a history of CD and lower MPV as factors associated with risk of lower extremity arterial embolism and thrombosis.